|4Mar 19, 4:48 PM ET

Leonard John E. 4

4 · VACCINEX, INC. · Filed Mar 19, 2019

Insider Transaction Report

Form 4
Period: 2019-03-15
Leonard John E.
SVP, Development
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-03-15+4,0004,000 total
    Exercise: $3.90Exp: 2029-03-14Common Stock (4,000 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $7.10Exp: 2025-12-23Common Stock (3,062 underlying)
    3,062
  • Common Stock

    (indirect: By LLC)
    1,014
  • Stock Option (Right to Buy)

    Exercise: $7.10Exp: 2025-12-22Common Stock (24,408 underlying)
    24,408
Footnotes (3)
  • [F1]Exercisable in full as of the date of this report.
  • [F2]This option has vested with respect to 2,449 shares and the remainder vests on December 23, 2019.
  • [F3]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT